Back to Search
Start Over
CN2 ECONOMIC EVALUATION OF NEW POLY-CHEMOTHERAPY REGIMENS AS ALTERNATIVES TO CISPLATIN PLUS PACLITAXEL IN ADVANCED NON-SMALL CELL LUNG CANCER
- Source :
- Value in Health. (6):443-444
- Publisher :
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
- Subjects :
- Oncology
Cisplatin
Chemotherapy
medicine.medical_specialty
business.industry
Health Policy
medicine.medical_treatment
Public Health, Environmental and Occupational Health
medicine.disease
chemistry.chemical_compound
Paclitaxel
chemistry
Internal medicine
Economic evaluation
Medicine
Non small cell
business
Lung cancer
skin and connective tissue diseases
health care economics and organizations
hormones, hormone substitutes, and hormone antagonists
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi.dedup.....d4cc26c491e7dfba7146192d352fd8b4
- Full Text :
- https://doi.org/10.1016/S1098-3015(10)61194-1